US Biotech Hits Back At Merck Over Tissue Regrowth Patent
A U.S. biotechnology company has maintained that its patent for engineered proteins that help generate eye tissue is inventive, arguing that Merck Sharp & Dohme has failed to back up its...To view the full article, register now.
Already a subscriber? Click here to view full article